Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

PALBOCICLIB SANDOZ CAPSULE 125MG

Approval Number

SIN17007P

Drug Name

PALBOCICLIB SANDOZ CAPSULE 125MG

Product Name

PALBOCICLIB SANDOZ CAPSULE 125MG

Approval Date

May 9, 2024

Registrant

NOVARTIS (SINGAPORE) PTE LTD

Regulatory Information

Registrant

NOVARTIS (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE

Route of Administration

ORAL

Medical Information

ATC Code

L01EF01

Manufacturer Information

Pharmaceutical Manufacturer

NOVARTIS (SINGAPORE) PTE LTD

Manufacturers

Aizant Drug Research Solutions Pvt Ltd.

Active Ingredients

Ingredient Name

Palbociclib

Strength

125.00 mg

Drug MonographPalbociclib

Documents

Package Inserts

PALBOCICLIB SANDOZ Capsule PI.pdf

Approved: May 9, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

PALBOCICLIB SANDOZ CAPSULE 125MG - HSA Approval | MedPath